Tazemetostat
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB12887 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | clear cell renal carcinoma | KG + DL |
| 2 | ovarian myxoid liposarcoma | KG + DL |
| 3 | liposarcoma | KG + DL |
| 4 | kidney pelvis sarcomatoid transitional cell carcinoma | KG + DL |
| 5 | prostatic urethra urothelial carcinoma | KG + DL |
| 6 | infiltrating bladder urothelial carcinoma sarcomatoid variant | KG + DL |
| 7 | renal pelvis papillary urothelial carcinoma | KG + DL |
| 8 | gastric adenocarcinoma | KG + DL |
| 9 | renal cell carcinoma associated with neuroblastoma | KG + DL |
| 10 | renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions | KG + DL |
| 11 | unclassified renal cell carcinoma | KG + DL |
| 12 | synovium cancer | KG + DL |
| 13 | genetic gastro-esophageal disease | KG + DL |
| 14 | rete ovarii cystadenoma | KG + DL |
| 15 | ovarian benign neoplasm | KG + DL |
| 16 | malignant giant cell tumor | KG + DL |
| 17 | ovarian papillary cystadenoma | KG + DL |
| 18 | childhood kidney cell carcinoma | KG + DL |
| 19 | ovarian mucinous cystadenofibroma | KG + DL |
| 20 | borderline ovarian serous tumor | KG + DL |
| 21 | serous neoplasm | KG + DL |
| 22 | ovarian surface papilloma | KG + DL |
| 23 | spindle cell liposarcoma | KG + DL |
| 24 | mucinous ovarian cystadenoma | KG + DL |
| 25 | renal cell adenocarcinoma | KG + DL |
| 26 | malignant ovarian Brenner tumor | KG + DL |
| 27 | vulva sarcoma | KG + DL |
| 28 | squamous cell lung carcinoma | KG + DL |
| 29 | undifferentiated carcinoma of liver and intrahepatic biliary tract | KG + DL |
| 30 | heart fibrosarcoma | KG + DL |
| 31 | kidney fibrosarcoma | KG + DL |
| 32 | classic variant of chromophobe renal cell carcinoma | KG + DL |
| 33 | mucinous ovarian cancer | KG + DL |
| 34 | childhood malignant kidney neoplasm | KG + DL |
| 35 | fibroblastic neoplasm | KG + DL |
| 36 | conventional fibrosarcoma | KG + DL |
| 37 | collecting duct carcinoma | KG + DL |
| 38 | bone fibrosarcoma | KG + DL |
| 39 | low grade fibromyxoid sarcoma | KG + DL |
| 40 | uterine corpus myxoid leiomyosarcoma | KG + DL |
| 41 | ovarian clear cell cancer | KG + DL |
| 42 | anus leiomyosarcoma | KG + DL |
| 43 | familial rhabdoid tumor | KG + DL |
| 44 | uterine corpus epithelioid leiomyosarcoma | KG + DL |
| 45 | small intestinal sarcoma | KG + DL |
| 46 | leiomyosarcoma | KG + DL |
| 47 | retroperitoneal sarcoma | KG + DL |
| 48 | nasopharyngeal teratoma | KG + DL |
| 49 | cutaneous undifferentiated pleomorphic sarcoma | KG + DL |
| 50 | tenosynovial giant cell tumor | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.